- Corporate Officers - B
- Baker Julian
Insider Trading History of Baker Julian
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Baker Julian since 2015.
This trader's CIK number is 1087939.
At the time of last reporting, Baker Julian was the Officer of Kymera Therapeutics, Inc.. (stock ticker symbol KYMR).
Also see all insider trading activities at Kymera Therapeutics, Inc..
Note that in the past
BAKER JULIAN also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Xoma Royalty Corp (XOMA) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | XOMA | 0 | $0 | 13,215,400 | $20,461,382 | 0 | $0 |
Yearly summary of insider trading at Talis Biomedical Corp (TLIS) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | TLIS | 6,250,000 | $100,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Beone Medicines Ltd. (ONC) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ONC | 0 | $0 | 732,827 | $190,535,020 | 0 | $0 |
| 2024 | ONC | 0 | $0 | 1,037,017 | $204,558,862 | 0 | $0 |
| 2021 | ONC | 0 | $0 | 121,154 | $26,714,457 | 0 | $0 |
| 2020 | ONC | 0 | $0 | 1,511,546 | $333,295,893 | 0 | $0 |
| 2018 | ONC | 7,794,298 | $827,922,798 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Rhythm Pharmaceuticals, Inc. (RYTM) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | RYTM | 885,000 | $15,045,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neurogene Inc. (NLTX) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | NLTX | 424,000 | $6,466,000 | 0 | $0 | 0 | $0 |
| 2019 | NLTX | 371,525 | $1,114,524 | 0 | $0 | 0 | $0 |
| 2017 | NLTX | 398,062 | $6,483,633 | 0 | $0 | 0 | $0 |
| 2016 | NLTX | 3,788,760 | $43,620,638 | 0 | $0 | 0 | $0 |
| 2015 | NLTX | 2,480,032 | $38,440,496 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tscan Therapeutics, Inc. (TCRX) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | TCRX | 1,425,000 | $21,375,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kala Bio, Inc. (KALA) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | KALA | 310,559 | $1,999,999 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bicycle Therapeutics Plc (BCYC) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | BCYC | 1,485,397 | $21,135,464 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Immunocore Holdings Plc (IMCR) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | IMCR | 807,338 | $23,938,379 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kymera Therapeutics, Inc. (KYMR) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | KYMR | 655,500 | $28,842,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alexion Pharmaceuticals, Inc. (ALXN) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ALXN | 500,000 | $39,357,381 | 0 | $0 | 0 | $0 |
| 2019 | ALXN | 0 | $0 | 300,000 | $37,086,968 | 0 | $0 |
Yearly summary of insider trading at Invitae Corp (NVTA) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | NVTA | 1,111,111 | $4,999,999 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Acadia Pharmaceuticals Inc (ACAD) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ACAD | 1,050,000 | $33,331,510 | 0 | $0 | 0 | $0 |
| 2019 | ACAD | 1,562,500 | $62,500,000 | 0 | $0 | 0 | $0 |
| 2018 | ACAD | 12,975,481 | $222,899,391 | 0 | $0 | 0 | $0 |
| 2017 | ACAD | 0 | $0 | 0 | $0 | 1,465,968 | $2,023,035 |
| 2016 | ACAD | 2,586,206 | $74,999,974 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Seagen Inc. (SGEN) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | SGEN | 0 | $0 | 0 | $0 | 35,000 | $665,700 |
| 2020 | SGEN | 0 | $0 | 2,808,316 | $451,414,258 | 35,000 | $446,600 |
| 2019 | SGEN | 0 | $0 | 0 | $0 | 20,000 | $167,600 |
| 2018 | SGEN | 1,460,651 | $75,895,266 | 0 | $0 | 20,000 | $201,600 |
Yearly summary of insider trading at Hookipa Pharma Inc. (HOOK) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | HOOK | 892,857 | $12,499,998 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Prelude Therapeutics Inc (PRLD) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | PRLD | 0 | $0 | 0 | $0 | 10,376 | $133,331 |
| 2020 | PRLD | 1,578,947 | $29,999,993 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bellicum Pharmaceuticals, Inc (BLCM) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | BLCM | 0 | $0 | 880,735 | $7,220,105 | 0 | $0 |
Yearly summary of insider trading at Incyte Corp (INCY) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | INCY | 0 | $0 | 0 | $0 | 30,000 | $1,470,300 |
| 2021 | INCY | 1,595,519 | $115,033,670 | 0 | $0 | 0 | $0 |
| 2020 | INCY | 2 | $205 | 0 | $0 | 40,000 | $533,600 |
Yearly summary of insider trading at Kodiak Sciences Inc. (KOD) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | KOD | 393,440 | $35,637,500 | 0 | $0 | 149,999 | $1,499 |
| 2020 | KOD | 1,304,886 | $66,117,614 | 0 | $0 | 0 | $0 |
| 2019 | KOD | 1,902,173 | $87,499,958 | 0 | $0 | 0 | $0 |
| 2018 | KOD | 2,500,000 | $25,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aceragen, Inc. (IDRA) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | IDRA | 0 | $0 | 0 | $0 | 20,316,327 | $9,548,673 |
| 2017 | IDRA | 8,000,000 | $12,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Igm Biosciences, Inc. (IGMS) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | IGMS | 0 | $0 | 0 | $0 | 22,420 | $630,786 |
| 2019 | IGMS | 3,144,000 | $50,304,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Kiniksa Pharmaceuticals International, Plc (KNSA) by Baker Julian
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | KNSA | 3,000,000 | $54,000,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 22 companies by Baker Julian:
1. Xoma Royalty Corp (XOMA)
2. Talis Biomedical Corp (TLIS)
3. Beone Medicines Ltd. (ONC)
4. Rhythm Pharmaceuticals, Inc. (RYTM)
5. Neurogene Inc. (NLTX)
6. Tscan Therapeutics, Inc. (TCRX)
7. Kala Bio, Inc. (KALA)
8. Bicycle Therapeutics Plc (BCYC)
9. Immunocore Holdings Plc (IMCR)
10. Kymera Therapeutics, Inc. (KYMR)
11. Alexion Pharmaceuticals, Inc. (ALXN)
12. Invitae Corp (NVTA)
13. Acadia Pharmaceuticals Inc (ACAD)
14. Seagen Inc. (SGEN)
15. Hookipa Pharma Inc. (HOOK)
16. Prelude Therapeutics Inc (PRLD)
17. Bellicum Pharmaceuticals, Inc (BLCM)
18. Incyte Corp (INCY)
19. Kodiak Sciences Inc. (KOD)
20. Aceragen, Inc. (IDRA)
21. Igm Biosciences, Inc. (IGMS)
22. Kiniksa Pharmaceuticals International, Plc (KNSA)
Table 1. Insider trading of Xoma Royalty Corp (XOMA) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-07-22 | XOMA | Sale | 11,000,000 | 1.09 | 12,023,000 |
| 2015-01-02 | XOMA | Sale | 212,100 | 3.55 | 753,803 |
| 2015-01-05 | XOMA | Sale | 1,003,300 | 3.81 | 3,824,579 |
| 2015-01-06 | XOMA | Sale | 1,000,000 | 3.86 | 3,860,000 |
Table 2. Insider trading of Talis Biomedical Corp (TLIS) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-02-17 | TLIS | Buy | 6,250,000 | 16.00 | 100,000,000 |
Table 3. Insider trading of Beone Medicines Ltd. (ONC) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-28 | ONC | Sale | 732,827 | 260.00 | 190,535,020 |
| 2024-12-09 | BGNE | Sale | 1,037,017 | 197.26 | 204,558,862 |
| 2021-01-04 | BGNE | Sale | 121,154 | 220.50 | 26,714,457 |
| 2020-12-04 | BGNE | Sale | 1,511,546 | 220.50 | 333,295,893 |
| 2018-08-02 | BGNE | Buy | 5,814,100 | 108.00 | 627,922,800 |
| 2018-01-18 | BGNE | Buy | 1,980,198 | 101.00 | 199,999,998 |
Table 4. Insider trading of Rhythm Pharmaceuticals, Inc. (RYTM) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-10-05 | RYTM | Buy | 885,000 | 17.00 | 15,045,000 |
Table 5. Insider trading of Neurogene Inc. (NLTX) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-07-07 | NLTX | Buy | 424,000 | 15.25 | 6,466,000 |
| 2019-08-06 | AQXP | Buy | 81,800 | 2.84 | 232,312 |
| 2019-08-07 | AQXP | Buy | 289,725 | 3.04 | 882,212 |
| 2017-01-09 | AQXP | Buy | 398,062 | 16.29 | 6,483,633 |
| 2016-09-20 | AQXP | Buy | 2,783,605 | 12.55 | 34,934,242 |
| 2016-03-16 | AQXP | Buy | 361,755 | 7.92 | 2,865,461 |
| 2016-03-15 | AQXP | Buy | 109,912 | 7.95 | 874,020 |
| 2016-01-22 | AQXP | Buy | 52,202 | 10.69 | 558,091 |
| 2016-01-26 | AQXP | Buy | 77,639 | 10.90 | 846,265 |
| 2016-01-25 | AQXP | Buy | 10,945 | 11.14 | 121,894 |
| 2016-01-19 | AQXP | Buy | 78,045 | 9.15 | 713,955 |
| 2016-01-20 | AQXP | Buy | 112,034 | 9.18 | 1,027,911 |
| 2016-01-15 | AQXP | Buy | 84,670 | 8.61 | 728,924 |
| 2016-01-14 | AQXP | Buy | 117,953 | 8.05 | 949,875 |
| 2015-09-10 | AQXP | Buy | 2,480,032 | 15.50 | 38,440,496 |
Table 6. Insider trading of Tscan Therapeutics, Inc. (TCRX) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-07-20 | TCRX | Buy | 1,425,000 | 15.00 | 21,375,000 |
Table 7. Insider trading of Kala Bio, Inc. (KALA) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-12-30 | KALA | Buy | 310,559 | 6.44 | 1,999,999 |
Table 8. Insider trading of Bicycle Therapeutics Plc (BCYC) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-12-13 | BCYC | Buy | 985,397 | 13.66 | 13,464,464 |
| 2024-12-16 | BCYC | Buy | 500,000 | 15.34 | 7,671,000 |
Table 9. Insider trading of Immunocore Holdings Plc (IMCR) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-17 | IMCR | Buy | 807,338 | 29.65 | 23,938,379 |
Table 10. Insider trading of Kymera Therapeutics, Inc. (KYMR) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-30 | KYMR | Buy | 655,500 | 44.00 | 28,842,000 |
Table 11. Insider trading of Alexion Pharmaceuticals, Inc. (ALXN) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-18 | ALXN | Buy | 81,379 | 82.09 | 6,680,483 |
| 2020-03-18 | ALXN | Buy | 50,902 | 79.79 | 4,061,368 |
| 2020-03-17 | ALXN | Buy | 102,421 | 77.14 | 7,901,063 |
| 2020-03-16 | ALXN | Buy | 265,298 | 78.08 | 20,714,467 |
| 2019-05-30 | ALXN | Sale | 57,449 | 121.07 | 6,955,178 |
| 2019-05-28 | ALXN | Sale | 123,489 | 126.12 | 15,574,556 |
| 2019-05-29 | ALXN | Sale | 119,062 | 122.27 | 14,557,234 |
Table 12. Insider trading of Invitae Corp (NVTA) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-03-28 | NVTA | Buy | 1,111,111 | 4.50 | 4,999,999 |
Table 13. Insider trading of Acadia Pharmaceuticals Inc (ACAD) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-16 | ACAD | Buy | 694,303 | 31.35 | 21,765,704 |
| 2020-03-17 | ACAD | Buy | 219,800 | 32.16 | 7,067,888 |
| 2020-03-18 | ACAD | Buy | 135,897 | 33.10 | 4,497,918 |
| 2019-09-20 | ACAD | Buy | 1,562,500 | 40.00 | 62,500,000 |
| 2018-11-30 | ACAD | Buy | 11,764,705 | 17.00 | 199,999,985 |
| 2018-09-20 | ACAD | Buy | 1,210,776 | 18.91 | 22,899,406 |
| 2017-11-27 | ACAD | Option Ex | 39,378 | 1.38 | 54,341 |
| 2017-10-13 | ACAD | Option Ex | 1,426,590 | 1.38 | 1,968,694 |
| 2016-01-07 | ACAD | Buy | 2,586,206 | 29.00 | 74,999,974 |
Table 14. Insider trading of Seagen Inc. (SGEN) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-05-14 | SGEN | Option Ex | 35,000 | 19.02 | 665,700 |
| 2020-05-15 | SGEN | Sale | 1,750,000 | 160.00 | 280,000,000 |
| 2020-05-06 | SGEN | Sale | 390,072 | 165.25 | 64,457,837 |
| 2020-05-07 | SGEN | Sale | 168,244 | 164.68 | 27,706,421 |
| 2020-05-08 | SGEN | Sale | 500,000 | 158.50 | 79,250,000 |
| 2020-04-23 | SGEN | Option Ex | 35,000 | 12.76 | 446,600 |
| 2019-04-29 | SGEN | Option Ex | 20,000 | 8.38 | 167,600 |
| 2018-05-04 | SGEN | Buy | 204,537 | 52.68 | 10,775,622 |
| 2018-05-07 | SGEN | Buy | 129,715 | 53.70 | 6,966,344 |
| 2018-05-08 | SGEN | Buy | 126,399 | 54.02 | 6,828,326 |
| 2018-05-01 | SGEN | Option Ex | 20,000 | 10.08 | 201,600 |
| 2018-05-02 | SGEN | Buy | 69,947 | 52.72 | 3,687,605 |
| 2018-04-30 | SGEN | Buy | 623,136 | 51.06 | 31,817,947 |
| 2018-05-01 | SGEN | Buy | 306,917 | 51.54 | 15,819,422 |
Table 15. Insider trading of Hookipa Pharma Inc. (HOOK) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-04-23 | HOOK | Buy | 892,857 | 14.00 | 12,499,998 |
Table 16. Insider trading of Prelude Therapeutics Inc (PRLD) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-01-27 | PRLD | Option Ex | 10,376 | 12.85 | 133,331 |
| 2020-09-29 | PRLD | Buy | 1,578,947 | 19.00 | 29,999,993 |
Table 17. Insider trading of Bellicum Pharmaceuticals, Inc (BLCM) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-01-19 | BLCM | Sale | 295,361 | 7.91 | 2,336,305 |
| 2018-01-18 | BLCM | Sale | 324,774 | 8.12 | 2,635,865 |
| 2018-01-17 | BLCM | Sale | 260,600 | 8.63 | 2,247,935 |
Table 18. Insider trading of Incyte Corp (INCY) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-05-07 | INCY | Option Ex | 30,000 | 49.01 | 1,470,300 |
| 2021-12-15 | INCY | Buy | 350,332 | 69.87 | 24,478,047 |
| 2021-12-16 | INCY | Buy | 169,315 | 71.98 | 12,186,955 |
| 2021-12-17 | INCY | Buy | 1,075,872 | 72.84 | 78,368,668 |
| 2020-05-28 | INCY | Buy | 2 | 102.55 | 205 |
| 2020-04-28 | INCY | Option Ex | 40,000 | 13.34 | 533,600 |
Table 19. Insider trading of Kodiak Sciences Inc. (KOD) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-09-30 | KOD | Buy | 86,932 | 95.83 | 8,330,606 |
| 2021-09-29 | KOD | Option Ex | 149,999 | .01 | 1,499 |
| 2021-09-16 | KOD | Buy | 1,153 | 94.59 | 109,064 |
| 2021-09-15 | KOD | Buy | 30,685 | 94.43 | 2,897,615 |
| 2021-09-07 | KOD | Buy | 57,501 | 93.12 | 5,354,263 |
| 2021-08-17 | KOD | Buy | 8,164 | 85.38 | 697,017 |
| 2021-08-18 | KOD | Buy | 22,584 | 88.38 | 1,995,996 |
| 2021-08-19 | KOD | Buy | 83,648 | 87.28 | 7,300,462 |
| 2021-08-11 | KOD | Buy | 53,523 | 86.05 | 4,605,440 |
| 2021-08-12 | KOD | Buy | 10,986 | 86.68 | 952,255 |
| 2021-08-13 | KOD | Buy | 38,264 | 88.72 | 3,394,782 |
| 2020-09-25 | KOD | Buy | 48,125 | 56.78 | 2,732,537 |
| 2020-09-22 | KOD | Buy | 74,958 | 50.62 | 3,794,149 |
| 2020-09-23 | KOD | Buy | 92,069 | 52.27 | 4,812,354 |
| 2020-09-24 | KOD | Buy | 36,020 | 51.76 | 1,864,467 |
| 2020-09-08 | KOD | Buy | 116,295 | 46.94 | 5,459,119 |
| 2020-09-04 | KOD | Buy | 82,801 | 46.67 | 3,864,157 |
| 2020-09-03 | KOD | Buy | 123,883 | 47.75 | 5,915,784 |
| 2020-08-19 | KOD | Buy | 3,869 | 46.99 | 181,792 |
| 2020-08-20 | KOD | Buy | 60,573 | 47.09 | 2,852,079 |
| 2020-08-21 | KOD | Buy | 139,044 | 48.52 | 6,746,832 |
| 2020-03-17 | KOD | Buy | 10,000 | 38.98 | 389,850 |
| 2020-03-16 | KOD | Buy | 104,600 | 39.97 | 4,180,966 |
| 2020-03-18 | KOD | Buy | 35,400 | 37.61 | 1,331,287 |
| 2020-02-25 | KOD | Buy | 206,126 | 58.42 | 12,042,293 |
| 2020-02-26 | KOD | Buy | 100,000 | 58.71 | 5,871,400 |
| 2020-02-24 | KOD | Buy | 71,123 | 57.34 | 4,078,548 |
| 2019-12-06 | KOD | Buy | 1,902,173 | 46.00 | 87,499,958 |
| 2018-10-09 | KOD | Buy | 2,500,000 | 10.00 | 25,000,000 |
Table 20. Insider trading of Aceragen, Inc. (IDRA) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-03-15 | IDRA | Option Ex | 20,316,327 | .47 | 9,548,673 |
| 2017-10-26 | IDRA | Buy | 8,000,000 | 1.50 | 12,000,000 |
Table 21. Insider trading of Igm Biosciences, Inc. (IGMS) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-01-27 | IGMS | Option Ex | 22,420 | 28.14 | 630,786 |
| 2019-09-20 | IGMS | Buy | 3,144,000 | 16.00 | 50,304,000 |
Table 22. Insider trading of Kiniksa Pharmaceuticals International, Plc (KNSA) by Baker Julian
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-29 | KNSA | Buy | 3,000,000 | 18.00 | 54,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Baker Julian
(Officer of Kymera Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.